Nest

Swiss blood testing company gets $2.5M for novel at-home system

By Jonah Comstock 05:35 pm May 9, 2017

DBS System, a Swiss company that makes a line of portable blood tests called HemaXis, has raised $2.5 million led by investiere. The funding was in Swiss francs, but the values of the currencies are currently approximately equal. Investiere contributed $800,000, Swiss pension fund Nest put in $700,000, and $1 million came from existing shareholders and angel investors. DBS stands for "dried blood...

Reader comments, Proteus $32M, webinar this week

By Brian Dolan 06:35 am January 27, 2014

More than a few MobiHealthNews readers were less than impressed by the predictions made in the PSFK and Intel report on wearables we covered last week. Here's one: Everydayfella: "There is exactly a 0 percent chance that implantables will be mainstream or even a viable marketplace by 2018... or 2028 for that matter. Good rule of thumb: Whatever an R&D scientist tells you for time-to-market,...